Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Dermatomyositis+1

Recruiting

Investigational

Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Irritable bowel syndrome

Recruiting

Investigational

Efficacy and Safety of Brenipatide (LY3537031) in Adults with Irritable Bowel Syndrome‑Constipation (IBS‑C) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:LY3537031

Contact Research Centre

Breast neoplasm

Recruiting

Registered drugNo placebo

Study of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Goserelin Acetate

Contact Research Centre

Myelofibrosis+1

Recruiting

Registered drug

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Crohn's disease

Recruiting

Registered drugNo placebo

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Rabies

Recruiting

Registered drugNo placebo

Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

Registered drugNo placebo

Belgium

Participants:18–64 years · Healthy volunteers

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Central nervous system lymphoma

Recruiting

Registered drugNo placebo

Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Endometriosis

Recruiting

Registered drugNo placebo

Letrozole During IVF/ICSI for Women with Endometriosis

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Letrozole

Contact Research Centre

HER2 positive breast cancer

Recruiting

Registered drugNo placebo

Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Juvenile idiopathic arthritis

Recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Filgotinib

Contact Research Centre

Obesity+2

Recruiting

Investigational

Study of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:LY3841136 SODIUM

Contact Research Centre

Find therapies in clinical trials near you

234 trials match your criteria

Dermatomyositis+1

Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

Irritable bowel syndrome

Efficacy and Safety of Brenipatide (LY3537031) in Adults with Irritable Bowel Syndrome‑Constipation (IBS‑C) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Breast neoplasm

Study of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer

Myelofibrosis+1

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Crohn's disease

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Rabies

Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

Non-small cell lung cancer+1

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Central nervous system lymphoma

Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

Endometriosis

Letrozole During IVF/ICSI for Women with Endometriosis

HER2 positive breast cancer

Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

Juvenile idiopathic arthritis

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

Obesity+2

Study of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.